Bristol Myers Squibb's major customers
McKesson accounted for 36% of Bristol Myers Squibb's revenue in FY 2025, about the same as 34% a year earlier.
Get an email when Bristol Myers Squibb's customer concentration changes
When a new annual report adds a 10% customer, drops one, or moves a share by 5 points or more, you get the change and the filing link. Up to 10 companies per address, no account, unsubscribe with one click.
Major customers of Bristol Myers Squibb
Customers that Bristol Myers Squibb named in its annual report as 10% or more of revenue. A missing year means the customer was below that line or not named.
| Customer | Share of revenue | Change vs prior year | History | Latest filing |
|---|---|---|---|---|
| McKessonMCK | 36% | from 34% | 7 years | FY 2025 · filed 11 Feb 2026 |
| CencoraCOR | 29% | from 29% | 5 years | FY 2025 · filed 11 Feb 2026 |
| Cardinal HealthCAH | 22% | from 22% | 7 years | FY 2025 · filed 11 Feb 2026 |
Formerly disclosed
| Customer | Share of revenue | Change vs prior year | History | Latest filing |
|---|---|---|---|---|
| Amerisorce Bergen | 25% | last FY 2022 | 4 years | FY 2022 · filed 14 Feb 2023 |
Suppliers that depend on Bristol Myers Squibb
Listed companies whose annual report names Bristol Myers Squibb as a customer worth 10% or more of their revenue. If Bristol Myers Squibb cuts orders or switches supplier, these are the companies that feel it.
Formerly disclosed
| Supplier | Its revenue from this company | Change vs prior year | History | Latest filing |
|---|---|---|---|---|
| Rigel PharmaceuticalsRIGL | 82% | last FY 2016 | 2 years | FY 2016 · filed 28 Feb 2019 |
| BridgeBio PharmaBBIO | 81% | last FY 2023 | 2 years | FY 2023 · filed 24 Feb 2026 |
| ExelixisEXEL | 52% | last FY 2013 | 3 years | FY 2013 · filed 29 Feb 2016 |
| Nektar TherapeuticsNKTR | 36% | last FY 2020 | 2 years | FY 2020 · filed 5 Mar 2024 |
| RepligenRGEN | 27% | last FY 2013 | 2 years | FY 2013 · filed 17 Mar 2015 |
About this data
US-listed companies must disclose revenue from any single customer that reaches 10% of their total (ASC 280). ShadowGraph reads these disclosures from the XBRL data of every 10-K and 20-F we scan, keeps one value per fiscal year (restatements replace earlier values) and links each number to its filing. Companies that describe a customer only as "Customer A" are not listed by name. Figures are as reported; nothing here is investment advice.
All companies · Latest dependency shifts · Bulk data and API